Atara Biotherapeutics Inc
NASDAQ:ATRA
Net Margin
Atara Biotherapeutics Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Net Margin Comparison
Atara Biotherapeutics Inc Competitors
| Country | US |
| Market Cap | 74m USD |
| Net Margin |
-3 221%
|
| Country | US |
| Market Cap | 293.2B USD |
| Net Margin |
9%
|
| Country | US |
| Market Cap | 141.2B USD |
| Net Margin |
24%
|
| Country | US |
| Market Cap | 101.4B USD |
| Net Margin |
37%
|
| Country | US |
| Market Cap | 98.2B USD |
| Net Margin |
30%
|
| Country | AU |
| Market Cap | 131.7B AUD |
| Net Margin |
17%
|
| Country | US |
| Market Cap | 82.3B USD |
| Net Margin |
21%
|
| Country | US |
| Market Cap | 43.1B USD |
| Net Margin |
-33%
|
| Country | US |
| Market Cap | 39.2B USD |
| Net Margin |
-69%
|
| Country | US |
| Market Cap | 27.6B USD |
| Net Margin |
12%
|
| Country | IE |
| Market Cap | 26.6B USD |
| Net Margin |
12%
|
Profitability Report
View the profitability report to see the full profitability analysis for Atara Biotherapeutics Inc.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Atara Biotherapeutics Inc's most recent financial statements, the company has Net Margin of -3 220.9%.
You don't have any saved screeners yet
